Cutting out certain amino acids — the building blocks of proteins — from the diet of mice slows tumour growth and prolongs survival, according to new research* published in Nature.
Researchers at the Cancer Research UK Beatson Institute and the University of Glasgow found that removing two non-essential amino acids — serine and glycine — from the diet of mice slowed the development of lymphoma and intestinal cancer.
The researchers also found that the special diet made some cancer cells more susceptible to chemicals in cells called reactive oxygen species.
Chemotherapy and radiotherapy boost levels of these chemicals in the cells, so this research suggests a specially formulated diet could make conventional cancer treatments more effective.
The next stage would be to set up clinical trials with cancer patients to assess the feasibility and safety of such a treatment.
Dr Oliver Maddocks, a Cancer Research UK scientist at the University of Glasgow, said: "Our findings suggest that restricting specific amino acids through a controlled diet plan could be an additional part of treatment for some cancer patients in future, helping to make other treatments more effective.
Professor Karen Vousden, Cancer Research UK's chief scientist and study co-author said: "This kind of restricted diet would be a short term measure and must be carefully controlled and monitored by doctors for safety. Our diet is complex and protein — the main source of all amino acids – is vital for our health and well-being. This means that patients cannot safely cut out these specific amino acids simply by following some form of home-made diet."
Amino acids are the building blocks that cells need to make proteins. While healthy cells are able to make sufficient serine and glycine, cancer cells are much more dependent on getting these vital amino acids from the diet.
However, the study also found that the diet was less effective in tumours with an activated Kras gene, such as most pancreatic cancer, because the faulty gene boosted the ability of the cancer cells to make their own serine and glycine. This could help to select which tumours could be best targeted by diet therapy.
Dr Emma Smith, science communication manager at Cancer Research UK, said: "This is a really interesting look at how cutting off the supply of nutrients essential to cancer cell growth and division could help restrain tumours.
"The next steps are clinical trials in people to see if giving a specialised diet that lacks these amino acids is safe and helps slow tumour growth as seen in mice. We'd also need to work out which patients are most likely to benefit, depending on the characteristics of their cancer."
###
For media enquiries contact Stephanie McClellan in the Cancer Research UK press office on 020 3469 5314 or, out of hours, on 07050 264 059.
Notes to editor:
- Maddocks et al. Modulating the therapeutic response of tumours to serine and glycine starvation. Nature
- This research was funded by Cancer Research UK and the European Research Council.
About Cancer Research UK
- Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research.
- Cancer Research UK's pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.
- Cancer Research UK receives no government funding for its life-saving research. Every step it makes towards beating cancer relies on every pound donated.
- Cancer Research UK has been at the heart of the progress that has already seen survival in the UK double in the last forty years.
- Today, 2 in 4 people survive their cancer for at least 10 years. Cancer Research UK's ambition is to accelerate progress so that by 2034, 3 in 4 people will survive their cancer for at least 10 years.
- Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
- Together with its partners and supporters, Cancer Research UK's vision is to bring forward the day when all cancers are cured.
For further information about Cancer Research UK's work or to find out how to support the charity, please call 0300 123 1022 or visit http://www.cancerresearchuk.org. Follow us on Twitter and Facebook.
Media Contact
Stephanie McClellan
[email protected]
44-203-469-5314
@CR_UK
http://www.cancerresearchuk.org
############
Story Source: Materials provided by Scienmag
